TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06247202 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06247202 — Safety Biomarker (SAF): Complement factor D
Genes: CFD; DF; PFD
Study NCT06247202 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06247202 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06247202 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT05622227 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05798871 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04531267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04531267 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04737109 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06351033 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06351033 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06351033 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06351033 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05074355 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05074355 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05464381 — Predictive Biomarker (PRD): ABCB5 mRNA
Genes: ABCB5
Study NCT05786638 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04707859 — Predictive Biomarker (PRD): TCP1 mRNA
Genes: TCP1; CCT1; CCTA
Study NCT04707859 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05471713 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06540859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04577157 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06047795 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06355882 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05099068 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05319873 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05319873 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05297058 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05750979 — Predictive Biomarker (PRD): DARS2 mRNA
Genes: DARS2
Study NCT05258370 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05436496 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05436496 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05621967 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04737044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04737044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06097273 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04670250 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06101134 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT05099172 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05099172 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05099172 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05300971 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05110755 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05654480 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04760184 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04896970 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06458218 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04919655 — Predictive Biomarker (PRD): CELSR1 mRNA
Genes: CELSR1; CDHF9; FMI2
Study NCT05239689 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05421663 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04289688 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT04793958 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06078800 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06657755 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT06657781 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT04704934 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00649545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01142414 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04409639 — Safety Biomarker (SAF): RAS pathway
Study NCT04644315 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05343091 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05343091 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04655807 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04655807 — Safety Biomarker (SAF): Interleukin 12
Study NCT06025045 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05347524 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05681559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05681559 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT05681559 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06281353 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT06464367 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT06208488 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT05934552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05513144 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05513144 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05513144 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05422729 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01691638 — Safety Biomarker (SAF): Interleukin 1
Study NCT06036966 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT06036966 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT05536128 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05536128 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06003881 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT04847388 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04399382 — Predictive Biomarker (PRD): S100A8 mRNA
Genes: S100A8; CAGA; CFAG; MRP8
Study NCT04399382 — Predictive Biomarker (PRD): Calgranulin B
Genes: S100A9; CAGB; CFAG; MRP14
Study NCT04399382 — Predictive Biomarker (PRD): TNC mRNA
Genes: TNC; HXB
Study NCT05290428 — Predictive Biomarker (PRD): PAX1 mRNA
Genes: PAX1; HUP48
Study NCT05290428 — Predictive Biomarker (PRD): JAM3 mRNA
Genes: JAM3; UNQ859/PRO1868
Study NCT05936606 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT05620342 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT05651204 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT04232657 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06208956 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05531747 — Predictive Biomarker (PRD): IFI16 mRNA
Genes: IFI16; IFNGIP1
Study NCT05531747 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT05531747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06394934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05027360 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05735210 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05924178 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06215690 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05811845 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT05811845 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04804891 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05045989 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05856955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05736575 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05736575 — Safety Biomarker (SAF): BDNF
Study NCT00002396 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05431244 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05444998 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06300593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06300593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05915962 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05208229 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05776641 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06058988 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04673383 — Predictive Biomarker (PRD): DMTN mRNA
Genes: DMTN; DMT; EPB49
Study NCT05329038 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06363305 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06278688 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06278688 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06278688 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT06278688 — Safety Biomarker (SAF): BDNF
Study NCT04925960 — Predictive Biomarker (PRD): PMM2 mRNA
Genes: PMM2
Study NCT04803123 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05033990 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT05070546 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05347745 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05990595 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06542510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06098222 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05018351 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06270004 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT00000923 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000923 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05941468 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04575363 — Predictive Biomarker (PRD): RPSA mRNA
Genes: RPSA; LAMBR; LAMR1
Study NCT05824468 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05297110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06376721 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05599958 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05599958 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT05168423 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05063071 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05063071 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06606028 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05221385 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06135116 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06135116 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT06135116 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT06055634 — Predictive Biomarker (PRD): SIRT7 mRNA
Genes: SIRT7; SIR2L7
Study NCT06055634 — Predictive Biomarker (PRD): HIC1 mRNA
Genes: HIC1; ZBTB29
Study NCT05217914 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06530043 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05742399 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06495749 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06198296 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT06198296 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT06198296 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): IL21 mRNA
Genes: IL21
Study NCT05939349 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06546111 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05067088 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05824143 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00190112 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06405971 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05947721 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05387356 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05571657 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05884398 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04904900 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06137430 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05679154 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT05699577 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06092047 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06139042 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05133050 — Predictive Biomarker (PRD): COL4A3 mRNA
Genes: COL4A3
Study NCT05133050 — Predictive Biomarker (PRD): COL4A4 mRNA
Genes: COL4A4
Study NCT05133050 — Predictive Biomarker (PRD): COL4A5 mRNA
Genes: COL4A5
Study NCT05133050 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05714904 — Predictive Biomarker (PRD): CYP4V2 mRNA
Genes: CYP4V2
Study NCT06227832 — Predictive Biomarker (PRD): SLC47A1 mRNA
Genes: SLC47A1; MATE1
Study NCT06227832 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05045404 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05456880 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05456880 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05587946 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05978999 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04645134 — Predictive Biomarker (PRD): GPLD1 mRNA
Genes: GPLD1; PIGPLD1
Study NCT05759884 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05759884 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04678687 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04605614 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06403904 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT06005324 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06191302 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05371873 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05622162 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05460234 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT06228508 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06340074 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05673408 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05664932 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05034848 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06399783 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05607069 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06351852 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06547463 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05456750 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study NCT06162013 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT06327230 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05503667 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05000853 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study NCT05229952 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT06624020 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06730035 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study NCT06731283 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT06731283 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT06731283 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study NCT05614050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06363162 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT06363162 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT06363162 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06363162 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06363162 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06363162 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT06363162 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT06363162 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06363162 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT06166836 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04833439 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT04945161 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study NCT04945161 — Predictive Biomarker (PRD): IL1RN mRNA
Genes: IL1RN; IL1F3; IL1RA
Study NCT04945161 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT04945161 — Predictive Biomarker (PRD): KRT14 mRNA
Genes: KRT14
Study NCT04945161 — Predictive Biomarker (PRD): MMP12 mRNA
Genes: MMP12; HME
Study NCT04945161 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02684383 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05433272 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05147805 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05570929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05593328 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05593328 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05585944 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05585944 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05585944 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05857332 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT06108739 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT04788563 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05620680 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05915039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05243173 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04673305 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05300373 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT05300373 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05573373 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06158529 — Predictive Biomarker (PRD): PDPN mRNA
Genes: PDPN; GP36; PSEC0003; PSEC0025
Study NCT06259929 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06259929 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT06259929 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06657235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06656442 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT05824156 — Predictive Biomarker (PRD): CCL24 mRNA
Genes: CCL24; MPIF2; SCYA24
Study NCT05519293 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05240443 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04630574 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05550558 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT05550558 — Predictive Biomarker (PRD): Microsatellite instability